Phase II study of vinorelbine in patients with hormone refractory prostate cancer

被引：0
|
作者：
Caty, A [1 ]
Oudard, S [1 ]
Humblet, Y [1 ]
Beauduin, M [1 ]
Suc, E [1 ]
Gil, T [1 ]
Rolland, F [1 ]
Houyau, P [1 ]
Sun, X [1 ]
Montcuquet, P [1 ]
Breza, J [1 ]
Favreau, E [1 ]
Tresca, P [1 ]
Chopin, D [1 ]
机构：
[1] CTR OSCAR LAMBRET,F-59020 LILLE,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [1] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
    Goodin, S
    Rao, KV
    Kane, M
    Dave, N
    Capanna, T
    Doyle-Lindrud, S
    Engle, E
    Jin, LX
    Todd, M
    DiPaola, RS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (02) : 199 - 204
  • [2] A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer
    Susan Goodin
    Kamakshi V. Rao
    Michael Kane
    Nisha Dave
    Terry Capanna
    Susan Doyle-Lindrud
    Elizabeth Engle
    Lixian Jin
    Mary Todd
    Robert S. DiPaola
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 199 - 204
  • [3] Vinorelbine and prednisone in older cancer patients with hormone-refractory metastatic prostate cancer - A phase II study
    Tralongo, P
    Bollina, R
    Aiello, R
    Di Mari, A
    Moruzzi, G
    Beretta, G
    Mauceri, G
    Conti, G
    TUMORI JOURNAL, 2003, 89 (01): : 26 - 30
  • [4] Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients
    Carles, Joan
    Domenech, Montserrat
    Gelabert-Mas, Antonio
    Nogue, Miquel
    Tabernero, Josep M.
    Arcusa, Angeles
    Guasch, Inmaculada
    Miguel, Ana
    Ballesteros, Juan J.
    Fabregat, Xavier
    Acta Oncologica, 37 (02): : 187 - 191
  • [5] Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients
    Carles, J
    Domenech, M
    Gelabert-Mas, A
    Nogue, M
    Tabernero, JM
    Arcusa, A
    Guasch, I
    Miguel, A
    Ballesteros, JJ
    Fabregat, X
    ACTA ONCOLOGICA, 1998, 37 (02) : 187 - 191
  • [6] Phase II study of oral vinorelbine plus hormone therapy in hormone-refractory prostate cancer
    Chiti, F.
    Calais da Silva, F. M.
    Canelas, A.
    Goncalves, P.
    Gomes, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II study of intravenous vinorelbine plus hormone therapy in hormone-refractory prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 95 - 95
  • [8] Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer
    Colleoni, M
    Graiff, C
    Vicario, G
    Nelli, P
    Sgarbossa, G
    Pancheri, F
    Manente, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 383 - 386
  • [9] A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer
    Galcerán J.C.
    Piulats R.B.
    Martín-Broto J.
    Rey P.M.
    Aligué M.N.
    Santasusana M.D.
    Lanza A.A.
    Molins J.B.
    Colin C.
    Girard A.
    Clinical and Translational Oncology, 2005, 7 (2) : 66 - 73
  • [10] Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    Perdona, Sisto
    De Laurentiis, Michele
    D'Armiento, Massimo
    Cancello, Giuseppe
    Mirone, Vincenzo
    Imbimbo, Ciro
    Longo, Nicola
    Altieri, Vincenzo
    Tortora, Gianpaolo
    Figg, William D.
    De Placido, Sabino
    EUROPEAN UROLOGY, 2007, 52 (04) : 1020 - 1027
12345